Chenxi'nan Ma

Mr. Chenxi'nan Ma


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2026 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
CMChenxi'nan Ma
Chenxi'nan Ma
LWLei Wu
Lei Wu
YLYaxi Li
Yaxi Li
BYBolu Yang
Bolu Yang
JTJie Tan
Jie Tan
TJTazeen H. Jafar
Tazeen H. Jafar
Key Points: Multicomponent interventions with two or more intervention strategies are increasingly used to manage patients with CKD G3-G4. Existing multicomponent interventions had a modest effect on slowing CKD progression, although the certainty of evidence was low for eGFR and moderate for eGFR slope. Among multicomponent interventions, physician-led team-based care seemed superior to non–physician-led team-based care, albeit the clinical relevance of the benefit was modest. Background: Various multicomponent interventions (MCIs) have been increasingly used for managing patients with CKD G3-G4, but they have not been systematically evaluated for the collective evidence of their effectiveness. Hence, we conducted this systematic review and meta-analysis to evaluate the effectiveness of MCIs in delaying CKD progression and improving health outcomes in patients with CKD G3-G4. Methods: We completed a systematic literature search in PubMed, Embase, Cochrane Central Register of Controlled Trials, Web of Science, and Cumulative Index to Nursing and Allied Health Literature from inception to July 30, 2025. We included randomized controlled trials studying the effectiveness of MCIs lasting at least 6 months among patients with CKD G3-G4. We used random-effects meta-analyses to estimate the effectiveness of MCIs on the primary outcome, eGFR, and secondary outcomes, including other kidney function indicators, CKD risk factors, and adverse events. Results: Nineteen randomized controlled trials (36,296 patients with CKD G3-G4; median follow-up of 24 months) were included. Components of MCI included a mix of behavioral modifications, guideline-directed medical therapy, enabling technology components, and team-based care. Compared with control, MCIs were associated with small improvements in eGFR (mean difference [MD]=1.18 ml/min per 1.73 m 2 ; 95% confidence interval [CI], 0.09 to 2.27; 19 trials, low certainty of evidence), eGFR slope (MD=0.61 ml/min per 1.73 m 2 /yr; 95% CI, 0.16 to 1.06; six trials, moderate certainty of evidence), and a moderate reduction in HbA1c (MD=−0.26; 95% CI, −0.49 to−0.02; nine trials, low certainty of evidence). No statistically significant effects were observed for albuminuria, BP, or adverse events. Conclusions: Our findings suggest the potential role of MCIs in delaying CKD progression and improving glycemic control among patients with CKD G3-G4. Nonetheless, the certainty of evidence is low for eGFR and HbA1c and moderate for eGFR slope, suggesting overall modest clinical relevance. High-quality studies are needed to confirm the effectiveness, cost-effectiveness, and scalability of MCIs for this high-risk patient group.

29 May 2026 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
HDHaozhe Ding
Haozhe Ding
KGKuiying Gu
Kuiying Gu
SYSumei Yuan
Sumei Yuan
QHQi Huang
Qi Huang
CMChenxi'nan Ma
Chenxi'nan Ma
ZWZhongxiao Wan
Zhongxiao Wan


19 November 2026 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
CMChenxi'nan Ma
Chenxi'nan Ma
MGMihir Gandhi
Mihir Gandhi
TJTazeen H. Jafar
Tazeen H. Jafar
Key Points: Lower Life's Essential 8 scores suggestive of poorer cardiovascular health were associated with a higher risk of incident ESKD. Associations were stronger for the biological than the behavioral subscale; smoking, physical activity, BP, and glucose were key factors. Our findings support the relevance of modifiable Life's Essential 8 health behaviors and clinical indicators as potential targets for preventive kidney health strategy. Background: Life's Essential 8 (LE8) is a comprehensive cardiovascular health metric integrating 8 behavioral and biological factors and has been associated with cardiovascular disease risk. However, evidence linking LE8 to ESKD is lacking. Methods: We analyzed the UK Biobank data prospectively on participants who were free of ESKD at baseline. The LE8 score, calculated as the unweighted average of 8 components (range, 0–100), was categorized as low (0–49), moderate (50–79), and high (80–100), with higher scores indicating more favorable health status. The primary outcome was incident ESKD, defined as needing KRT or reaching CKD stage G5. We used Cox proportional hazards models to estimate hazard ratios (HRs) for incident ESKD, separately for LE8 categories and for continuous LE8 scores, with nonlinear associations assessed using restricted cubic splines. We also estimated population-attributable fractions for nonoptimal LE8 and its subscales and components. Results: Among 276,494 participants (mean [SD] age 56 [8] years; 48% male; 95% White), 455 incident ESKD events occurred over a median follow-up of 14.1 years. In fully adjusted Cox models, each 10-point decrement in LE8 score was associated with higher ESKD risk (HR, 1.47; 95% confidence interval [CI], 1.34 to 1.60). Compared with high LE8, moderate LE8 was associated with a 2.1-fold higher risk of incident ESKD (HR, 2.11; 95% CI, 1.39 to 3.21), and low LE8 was associated with a more than five-fold higher risk (HR, 5.57; 95% CI, 3.42 to 9.07). Subscale analyses showed similar patterns. Restricted cubic splines analysis suggested nonlinear associations for overall LE8 and the biological subscale, with steeper risk gradients at lower scores. BP, blood glucose, physical activity, and smoking had statistically significant estimated population-attributable fractions for incident ESKD, with the largest fractions observed for BP and blood glucose. Conclusions: In this large prospective cohort, lower LE8 scores were associated with a higher risk of incident ESKD. These findings highlight the potential relevance of LE8-guided improvement in behavioral and biological factors for ESKD prevention.